Login Open account
Australia
By using our website you agree to our use of cookies in accordance with our cookie policy.
Okay
Macro Macro Macro

Macro Dragon: Welcome to WK # 42 - 3Q Earnings, Brexit, EU Council, NZ Elections, US Stimulus?

Macro 2 minutes to read

Summary:  Macro Dragon = Cross-Asset Daily Views that could cover anything from tactical positioning, to long-term thematic investments, key events & inflection points in the markets, all with the objective of consistent wealth creation overtime.

(These are solely the views & opinions of KVP, & do not constitute any trade or investment recommendations. By the time you synthesize this, things may have changed.)

Macro Dragon: Welcome to WK # 42 - 3Q Earnings, Brexit, EU Council, NZ Elections, US Stimulus?

 

Top of Mind…

  • Happy Monday Folks & Welcome to WK # 42…

  • Hope everyone had an abundant filled wkd

  • What kind of week are you trying to have up ahead?

  • Focus: Again very much still US politics to dominate until the election results are clear, especially given Trump’s Covid-19 & 180 flip (as we postulated) on a stimulus bill. Note the US is out for a long wkd & back in fully on Tues. Still the nomination of ACB to fill RBG seat on the Supreme court should kick off today with a vote expected before Nov.

  • Anything is still possible in regards to potential presidential debates: Dragon’s ring-side coaching to one of the teams is to bin one of the debates, among other advice going forward

  • Whilst the situation is still dynamic, it looks like for Oct 15, Biden is hosting a townhall – given the WH turned down a virtual debate.

  • Whether we will see one more Trump vs. Biden, remains to be seen – it looks like the doctors have cleared Trump to be able to leave the WH, saying he is no longer considered a transmission risk, yet not confirmation about him testing negative for Covid-19 – likely because he still has Covid. Worth noting so far, he seems to be holding up well.

  • It is worth noting that developments on the side of Brexit continue with Oct 15 deadline, yet are not gaining the headlines & focus they normally would.

  • We also have election in NZ, where the incumbent is expected to easily secure the next term. Plus coming Fri & WKD will see IMF meetings whose conclusion will likely be – we need more fiscal, risk to recovery if fiscal stalls, global healthcare framework is needed, etc.

  • Markets: Really all about the Stimulus, the move on Fri was very much on talks that trump wanted a fiscal deal. It’s unclear how much of an effect the kick-off of 3Q earnings will have.

  • Earnings: A number of banks will be reporting their earnings this wk including JPM, Citi, BoA, GS, MS, WTC, UBS & MS. A few other big names are Blackrock, United Health, Honeywell & chipmaker TSM.

  • There are a number of interesting charts to look into, including: lower lows in USDCNH, GBPUSD / Bitcoin / Gold / Silver tactically breaking out higher from recent trading ranges, the emerging market etf (EEM) breaking out higher…

  • …as are Caterpillar [CAT] + Deere & Co [DE]…

  • …with the Nikkei & ASX looking to break-out higher on previous resistance lvls…

  • Economics: Inflation themes wk with key figs out of US, CH + EZ. Also have GER ZEW & Aus jobs data.

  • Central Banks: Indonesia 4.0%e/p, South Koreas 0.50%e/p, Chile 0.50%e/p

    BOE’s Bailey set to speak on Tue 13 Oct 00:00 SGT, RBA’s Lowe set to speak on Thu 15 Oct 05:45 SGT

  • Fed Speak: Quarles 3x, Clarida @ 21:00 (Wed 14 Oct), Kaplan 2x & Kashkari

  • Holidays: US & CA out on Mon (12 Oct)

-

Start-to-End = Gratitude + Integrity + Vision + Tenacity. Process > Outcome. Sizing > Idea.

This is the way 

KVP

Quarterly Outlook Q2 2022: The End Game has arrived

  • The End Game has arrived

    Shocks from covid and the war in Ukraine have forced the global financial and political world to change, but what will the end game be?
    Read article

  • Productivity and innovation have never been more important

    As the world economy hits physical limits and central banks tighten their belts, could equities be facing a 10-15% downside?
    Read article

  • The great EUR recovery and the difficulty of trading it

    If the terrible fog of war hopefully lifts soon, the conditions are promising for the euro to reprice significantly higher.
    Read article

  • Tight commodity markets – turbocharged by war and sanctions

    With supply already tight, commodities keep powering on. But will it last for yet another quarter?
    Read article

  • Between a rock and a hard place

    Geopolitical concerns will add upward price pressures and fears of slower growth, while volatility will remain elevated.
    Read article

  • The Great Erosion

    Inflation is everywhere and central banks try to combat it. But will they get it under control in time?
    Read article

  • Australian investing: Six considerations amid triple Rs: rising rates, record inflation and likely recession

    While global financial markets are struggling in an uncertain world, the commodity-heavy Australian ASX index is poised to keep a positive momentum.
    Read article

  • Cybersecurity – the rush to catch up with reality

    With the invasion of Ukraine, governments and private companies are rushing to reinforce their cyber defenses.
    Read article
Disclaimer

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000
Australia

Contact Saxo

Select region

Australia
Australia
Products & pricing
Platforms
Accounts & service
General
Other
Legal

Trading can result in losses. Please ensure you understand the risks.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.